Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Recurrence of retinopathy of prematurity following bevacizumab monotherapy: is it only the tip of the iceberg?

Mireskandari K, Adams GG, Tehrani NN.

JAMA Ophthalmol. 2013 Apr;131(4):544-5. doi: 10.1001/jamaophthalmol.2013.711. No abstract available.

PMID:
23579608
2.

Need for revised screening protocol for early detection of retinopathy of prematurity in infants born before 25 weeks.

Kishore K, Macwan KS.

JAMA Ophthalmol. 2013 Apr;131(4):546-7. doi: 10.1001/jamaophthalmol.2013.1417. No abstract available.

PMID:
23579609
3.

In reply to Mireskandari and coworkers.

Blair MP, Shapiro MJ.

JAMA Ophthalmol. 2013 Apr;131(4):546-7. doi: 10.1001/jamaophthalmol.2013.35. No abstract available.

PMID:
23579610
4.

Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity.

Azad R, Chandra P.

Indian J Ophthalmol. 2007 Jul-Aug;55(4):319; author reply 320. No abstract available.

5.

Prolonged follow-up period following intravitreal bevacizumab injection for stage 3+ retinopathy of prematurity.

de Klerk TA, Park DY, Biswas S.

Eye (Lond). 2013 Oct;27(10):1218. doi: 10.1038/eye.2013.148. Epub 2013 Jul 12. No abstract available.

6.

Significant treatment failure with intravitreous bevacizumab for retinopathy of prematurity.

Patel RD, Blair MP, Shapiro MJ, Lichtenstein SJ.

Arch Ophthalmol. 2012 Jun;130(6):801-2. doi: 10.1001/archophthalmol.2011.1802. No abstract available.

PMID:
22801851
7.

Intravitreal bevacizumab as supplemental treatment or monotherapy for severe retinopathy of prematurity.

Axer-Siegel R, Snir M, Ron Y, Friling R, Sirota L, Weinberger D.

Retina. 2011 Jul-Aug;31(7):1239-47. doi: 10.1097/IAE.0b013e31820d4000.

PMID:
21555969
8.

[Retinopathy of prematurity].

Jandeck C, Stahl A.

Klin Monbl Augenheilkd. 2012 May;229(5):559-75; quiz 576-7. doi: 10.1055/s-0031-1298437. Epub 2012 May 16. German. No abstract available.

PMID:
22592347
9.

Bevacizumab (Avastin) for retinopathy of prematurity: wrong dose, wrong drug, or both?

Avery RL.

J AAPOS. 2012 Feb;16(1):2-4. doi: 10.1016/j.jaapos.2011.11.002. Epub 2012 Jan 10. No abstract available.

PMID:
22237669
10.

[Alarming use of anti-VEGF therapy in premature infants].

Hård AL, Hellström A.

Lakartidningen. 2011 Dec 7-13;108(49):2600. Swedish. No abstract available.

PMID:
22468401
11.

A new, theoretically safer method of intravitreal injection of bevacizumab in progressive retinopathy of prematurity using scleral trans-illumination.

Patel CK, Walker NJ, Kam JK.

Br J Ophthalmol. 2010 Aug;94(8):1107-9. doi: 10.1136/bjo.2009.162156. Epub 2010 Jun 16. Review. No abstract available.

PMID:
20558426
12.

Adjunctive effect of intravitreal bevacizumab prior to lens-sparing vitrectomy in aggressive posterior retinopathy of prematurity: a case report.

Sun HJ, Choi KS, Lee SJ.

Jpn J Ophthalmol. 2012 Sep;56(5):476-80. doi: 10.1007/s10384-012-0141-8. Epub 2012 Jul 28.

PMID:
22843138
13.

Bevacizumab for retinopathy of prematurity.

Reynolds JD.

N Engl J Med. 2011 Feb 17;364(7):677-8. doi: 10.1056/NEJMe1100248. No abstract available.

PMID:
21323546
14.

Bevacizumab for retinopathy of prematurity.

Good WV, Palmer EA.

N Engl J Med. 2011 Jun 16;364(24):2359; author reply 2361-2. doi: 10.1056/NEJMc1103460#SA1. No abstract available.

PMID:
21675899
15.

Intravitreal bevacizumab in retinopathy of prematurity: an interventional case series.

Roohipoor R, Ghasemi H, Ghassemi F, Karkhaneh R, Riazi-Esfahani M, Nili-Ahmadabadi M.

Graefes Arch Clin Exp Ophthalmol. 2011 Sep;249(9):1295-301. doi: 10.1007/s00417-011-1678-9. Epub 2011 Apr 15.

PMID:
21494873
16.

Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.

O'Keefe M.

Ir Med J. 2011 Jul-Aug;104(7):197. No abstract available.

PMID:
21957683
17.

Bevacizumab for retinopathy of prematurity.

Gole GA, Camuglia JE, Ells AL.

N Engl J Med. 2011 Jun 16;364(24):2360-1; author reply 2362. doi: 10.1056/NEJMc1103460#SA4. No abstract available.

PMID:
21675896
18.

Avastin as monotherapy for retinopathy of prematurity.

Mintz-Hittner HA.

J AAPOS. 2010 Feb;14(1):2-3. doi: 10.1016/j.jaapos.2009.12.002. No abstract available.

PMID:
20227612
19.

Bevacizumab for retinopathy of prematurity.

Gilbert CE, Zin A, Darlow B.

N Engl J Med. 2011 Jun 16;364(24):2359-60; author reply 2361-2. doi: 10.1056/NEJMc1103460#SA2. No abstract available.

PMID:
21675898
20.

Bevacizumab for retinopathy of prematurity.

Lim LS, Mitchell P, Wong TY.

N Engl J Med. 2011 Jun 16;364(24):2360; author reply 2361-2. doi: 10.1056/NEJMc1103460#SA3. No abstract available.

PMID:
21675897

Supplemental Content

Support Center